SCHEMBL5801220

SCHEMBL5801220

COc1ccc(CCC(=O)NCc2ccc(NS(C)(=O)=O)c(F)c2)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5800784 0.89 TRPV1 (0.53)
SCHEMBL4888448 0.81 TRPV1 (0.71)
SCHEMBL5801493 0.81 TRPV1 (0.59)
SCHEMBL4882968 0.81 TRPV1 (0.71)
SCHEMBL5276015 0.81
SCHEMBL5272159 0.80 TRPV1 (0.51)
SCHEMBL4887198 0.78
SCHEMBL14397747 0.78
SCHEMBL4028185 0.78 KMT2A (0.73) KMT2AMEN1
SCHEMBL5947622 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006098554-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-21 WO disclosed